Background Despite our awareness of the significant effect of smoking on multiple sclerosis (MS), there was a serious lack of information about the effect of different types of smoking habit on MS as well as the dose-response relationship between smoking and MS, but this gap was addressed by this meta-analysis.
Introduction
Multiple sclerosis (MS) is a progressive disorder of the white matter of the central nervous system in which myelin and axons are damaged. 1, 2 MS is one of the most common neurological disorders in young adults with an estimated prevalence of 30 per 100 000. 3 The disease typically begins between the ages of 20 and 50, with a peak occurring at 30 years of age. 4 MS is more common in women than in men. 5 The cause of MS is unknown; however, it is believed that MS is a multifactorial disease in which a combination of genetic susceptibility and environmental factors play an important role in the pathogenesis of the disease. 6 -8 Factors that are generally confirmed to be associated with an increased risk of MS are family history, 2 geographic variation, 4 vitamin D deficiency, 9 some infectious agents 2, 6 and certain autoimmune diseases. 10, 11 Several epidemiological studies have reported the association between smoking and MS. However, the results of OR estimates are inconsistent and vary from 1.03-to 7.60-fold. 12 -15 To date, several reviews, but only four meta-analyses 16 -19 have been performed to summarize the association between smoking and MS. A meta-analysis was conducted in 2005 on epidemiological studies to estimate the effect of ever versus never smoking habits on MS giving a pooled estimate of 1.51 (95% CI: 1.24, 1.83). 16 Another meta-analysis was performed on studies published until May 2010 to address the association between smoking and MS reporting an overall estimate of 1.48 (95% CI: 1.35, 1.63). 19 The third meta-analysis was conducted on studies published before 2011 to address the association between smoking and MS giving an overall estimate of 1.57 (95% CI: 1.41, 1.76). 17 A recently published meta-analysis was conducted to estimate the pooled estimate effect of smoking on MS and reported an odds ratio (OR) estimate of 1.54 (95% CI: 1.41, 1.67). 18 However, these meta-analyses had a number limitations and potential biases, including unclear search strategies, enrolling a limited number of studies and searching a single main database. But the main limitation of these meta-analyses was that they did not distinguish among different kinds of smoking habits (ever smoking, current smoking, ex-smoking and passive smoking). Despite our awareness of the significant effect of smoking on MS, there was a serious lack of information about the effect of different types of smoking habits on MS as well as the dose-response relationship between smoking and MS. This gap was addressed by this meta-analysis.
Materials and methods
This meta-analysis was approved and funded by the Vice-chancellor of Research and Technology, Hamadan University of Medical Sciences.
Eligibility criteria
The outcome of interest was MS, which is primarily an inflammatory disorder of the central nervous system in which focal lymphocytic infiltration leads to damage of myelin and axons. 2 The exposure of interest was smoking. Based on the smoking status, the participants were classified as nonsmokers (had never smoked or smoked less than 100 cigarettes), ex-smokers, called former smoker (had smoked more than 100 cigarettes, but had not smoked in the past 30 days) and current smokers (had smoked more than 100 cigarettes and had smoked in the past 30 days). 20 Passive smokers, the so-called second-hand smokers, are subjects who inhaled other people's tobacco smoke. Ever smoker, a combination of ex-smokers and current smokers, means people who were smokers whether or not stopped smoking.
Epidemiological studies, including cohort, case -control and cross-sectional studies, addressing the effect of smoking on MS were included irrespective of language, date of publication, nationality, race, age and gender. However, the results of different designs were analyzed in separate. The studies that investigated the incidence rate of MS among smokers without control group were excluded.
Information sources and search
Major electronic databases, including PubMed, Web of Science and Scopus were searched until July 2015. The reference lists of the included studies were searched and the study authors were contacted to identify additional studies.
The following search terms were used individually and in combination: Multiple sclerosis or Disseminated sclerosis or MS) and (Smoking or Tobacco or Cigarette or Cigar.
Study selection
We merged search results obtained from different databases using EndNote software, and removed duplicate records of the same report. Then, two authors screened independently titles and abstracts to remove obviously irrelevant reports. Disagreements were resolved by discussion. We retrieved and examined the full text of the potentially relevant studies. In cases, where there were multiple reports of the same study, the last published report was used. Between authors' agreement in selecting studies was quantified using kappa statistics (74.5%).
Data extraction
Two authors extracted data independently from every report to minimize errors using an electronic data collection form. Disagreements were resolved by discussion. We contacted corresponding authors, where appropriate, to request further information, such as missing results. However, some authors did not respond. The electronic data collection form included the following information: first author's name, year of publication, country, mean age, gender, smoking status, study design (cohort, case -control, cross-sectional), effect size (risk ratio, OR), controlling for confounding (adjusted, unadjusted), sample size, effect estimate with associated 95% confidence interval (CI).
Methodological quality
The quality of reporting of the included studies was explored using Newcastle Ottawa Statement (NOS) Manual. 21 The NOS scale provides a checklist of items for judging the risk of bias in the included studies and allocates a maximum of nine stars to the following domains: selection, comparability, exposure and outcome. In this meta-analysis, the studies with seven star-items or more were considered high-quality studies and those with six star-items or less were considered lowquality studies.
Heterogeneity and reporting biases
Heterogeneity was explored using Q-test. 22 The quantity of heterogeneity was measured using the I 2 statistic which is a useful statistic for quantifying inconsistency is as follows:
where Q is the x 2 statistic and df is its degrees of freedom. 23 The possibility of publication bias was explored using Begg's 24 and Egger's 25 tests. The Begg adjusted rank correlation test is a direct statistical analogue of the visual funnel graph. This procedure tests for publication bias by determining if there is a significant correlation between the effect estimates and their variances. 24 The Egger regression asymmetry test predicts the discordance of meta-analytic results and suggests the presence of publication bias. 25 
Summary measures
In this meta-analysis, we defined a cigarette pack-year as a pack of cigarettes (20 cigarettes) smoked every day for one year. We reported the association between smoking and MS using risk ratio (RR) and OR with their 95% CI. Risk describes the probability with which a health outcome (e.g. MS) will occur. Odds is the ratio of the probability that a particular event (e.g. MS) will occur to the probability that it will not occur. The RR is the ratio of the risk of an event in the two groups, whereas the OR is the ratio of the odds of an event in the two groups. 22 Wherever reported, we used full adjusted forms of RR and OR controlled for at least two or more potential confounding factors such as age, gender, educational level, ethnicity, sunlight exposure, residential area and latitude. We used the adjusted forms of RR and OR to report the overall effect of smoking on MS. However, in some studies, the effect of smoking on MS was reported by gender. We used such data to perform subgroup analysis by gender to estimate the effect of smoking on MS for men and women in separate.
Data were analyzed and the results were reported using a random effects model. 26 All statistical analyses were performed at a significance level of 0.05 using Stata software, version 11 (StataCorp, College Station, TX, USA).
Subgroup analysis
Subgroup analyses were performed based on the following items: (i) type of smoking habits (current smokers, ex-smokers, ever smoker and passive smoker); (ii) cigarette pack-year (1 -5, 6-10, 11 -15 and .15 years); (iii) effect size (risk ratio, OR); (iv) quality of reporting (high-quality, lowquality) and (v) gender (female and male).
Results

Results of the search
We identified a total of 10 687 references, including 10 159 references through the electronic searches and 528 through screening reference lists or contacting authors of studies until July 2015. We excluded 3590 duplicates and 7003 clearly irrelevant references through reading titles and abstracts. Accordingly, 94 references were retrieved for further assessment. We excluded 60 references because they did not meet our inclusion criteria. Thirty-four studies fulfilled our inclusion criteria (Fig. 1) . A total of 623 852 participants were involved in the 34 studies, including five cohort studies, 27 -31 28 case-control studies 12 -15,32 -55 and one cross-sectional study. 56 Thirty studies reported adjusted effect size (all controlled for at least age and sex) and four studies reported crude effect size. Thirty-two studies were published as full paper articles and two studies were published in abstract form 34, 54 (Table 1) . The quality of reporting of the included studies was explored using NOS manual. Based on this scale, six studies were high-quality, 12, 35, 36, 43, 46 ,49 26 studies were low-quality and two studies were published in abstract form 34, 54 and hence their quality assessment was impossible.
Synthesis of results
The association between MS and different types of smoking status is given in Figs 2 -5. Based on these forest plots, compared with nonsmokers, the OR estimate of MS was 1.46 (95% CI: 1.33, 1.59, I
2 ¼ 71.0%, 26 studies) among ever smokers (Fig. 2) 42 The effect of cigarette pack-year on MS is given in Fig. 5 . According to this forest plot, the OR estimate of MS was 1.34 2 ¼ 68.8%, 2 studies) for more than 15 cigarette pack-years.
Publication bias
The possibility of publication bias was explored using Begg's and Egger's tests. Based on Begg's test, there was no evidence of publication bias among studies addressing the risk of MS among ever smokers (P ¼ 0.442), current smokers (P ¼ 0.484), and ex-smokers (P ¼ 0.297). According to the results of Egger's test, there was a possibility of publication bias in studies reporting the risk of MS among ever smokers (P ¼ 0.003), but no evidence publication bias in studies reporting MS among current smokers (P ¼ 0.515) and ex-smokers (P ¼ 0.212).
Subgroup analysis
The effect of smoking habits on MS was investigated by gender. Based on this meta-analysis results, the effect of smoking habits on MS seems to be stronger in men than in women, although the results are not statistically significant for some OR estimates. CI: 1.31, 1.64) among ever smokers and 1.61 (95% CI: 1.44, 1.78) among current smokers.
Discussion
We summarized the available evidence from observational studies addressing the association between different kinds of smoking habits and MS. Our results suggested that the smoking habits of any kind were significantly associated with an increased risk of MS, although the association was not very strong. Furthermore, there was a positive association between MS and the number of cigarette pack-years, indicating an apparent dose -response relationship between the severity of cigarette smoking and MS. When, a dose -response Hernan 2001 Thorogood 1998
Effect size (95% Cl) relationship is present, it favors a causal relationship. 57 Nonetheless, the association between smoking and MS does not seem to be very strong. O'Gorman et al. 18 performed a meta-analysis in 2014 to examine the association between smoking and MS and reported an OR of about 1.5. They found out that males smokers were at higher risk for MS than female smokers. Handel et al. 19 also conducted a meta-analysis to assess the effect of smoking on MS risk. Their results reported a RR of 1.48 and concluded that smoking may increase the susceptibility to MS. Previous meta-analyses as well as ours indicated that smoking is significantly associated with an increased risk of MS, although the association is not strong enough.
There was no evidence of substantial heterogeneity across the included studies except for studies reporting the risk of MS among ever smokers. Although the results of studies were relatively consistent, the test of heterogeneity was statistically significant (P ¼ 0.001). An important reason that may explain the observed heterogeneity across studies is that individual studies come from different settings with different populations, sample sizes and methodological quality. Furthermore, the exposure of interest was a behavior, therefore, the possibility of measurement bias is expected. However, care must be taken in the interpretation of the Q-test. There is a problem with the test, which may occur in meta-analysis of observational studies with many studies or with large sample size. When there are many studies in a meta-analysis, as was the case in our meta-analysis, the test has high power to detect a small amount of heterogeneity that may be clinically unimportant and vice versa. 58 Several studies have been conducted to provide evidence explaining the mechanism by which smoking leads to MS in genetically susceptible people. There is a potential interaction between certain genotypes and smoking. Experimental studies have shown that exposure to cigarette smoking may increase the genetic susceptibility attributable to established genetic factors (DRB1 and HLA-A). Smoking can influence the risk of developing MS by modification of lung proteins and priming circulating lymphocytes against cross-reacting central nervous system antigens in genetically susceptible people. 59, 60 However, more investigations are needed to explain the pathophysiology by which smoking habits increase the risk of MS.
There were three outliers among the included studies with extreme results. We explored the reason for such different measures of effect. The first one 55 was a low-quality case-control study in which 100 patients with MS were compared with 100 controls. This study reported that cigarette smoking had a protective effect against MS (OR ¼ 0.17), but after controlling for other covariates the association was nonsignificant. Further evaluation of the proportion of smokers in cases and control revealed that 27.0% of controls were smokers while only 6.1% of the cases were smokers. This difference between the two groups may explain why this study introduced cigarette smoking as a protective factor against MS. The second one 42 was a low-quality case-control study in which 516 cases were compared with 1090 controls. This study reported that ex-smoking habit could increase the risk of MS by 8.83-fold. Only 16 out of 516 cases and 12 out of 1090 controls were ex-smokers. The limited number of ex-smokers in the two groups may raise the possibility of random error and may explain the reason of such an extreme risk of MS among ex-smokers.
The third one 14 was a low quality case-control study in which 81 patients with MS were compared with 81 paired controls. The cases and controls were matched for gender, age (+5 years) and place of birth. This study reported that ever smoking could increase the risk of MS by 7.6-fold. There was not any significant difference in the distribution of the nonmatched covariates between the two groups. We did not find a reasonable difference between cases and control groups to explain why such an extreme association was reported.
Our study had a few limitations as follows: (i) we performed subgroup analysis to assess the effect of different kinds of smoking habits on MS. However, the number of studies in some subgroups was limited. This may affect the reliability of the results of subgroup analyses. (ii) We attempted to use an adjusted form of the RR or OR estimates. Nonetheless, five studies did not report adjusted forms of the effect size. This issue may raise the possibility of information bias. (iii) A majority of the studies (26 out of 34) were low-quality raising the possibility of bias in the included studies.
Despite its limitations, this meta-analysis provided good evidence of association between MS and different kinds of smoking habits. In addition, this meta-analysis indicated an apparent dose-response relationship between the severity of smoking habits and MS. The amount of studies and body of evidence identified allow a robust conclusion regarding the objective of the study for estimating the effect of smoking habits on MS, thus, it seems that further research is very unlikely to change our confidence in the estimate of effect.
Conclusion
This meta-analysis addressed the association between different types of smoking habits and MS. This study indicated that former and current smokers are significantly at higher risk of MS. Even ex-smokers are at higher of MS than nonsmokers, although the association is not statistically significant. In addition, the dose -response relationship between cigarette smoking and MS was examined. The greater the number of cigarettes smoked per day, the higher the risk of MS will be. This issue justifies that efforts to reduce tobacco use may help reduce the risk of noncommunicable diseases including MS.
